SCHEMBL5201283

SCHEMBL5201283

CC(C)(O)C(=O)Nc1cc[c]cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.54
PDK1 Q15118 8/20 0.46
PDK2 Q15119 8/20 0.46
PDK3 Q15120 8/20 0.46
PDK4 Q16654 8/20 0.46
MAPT P10636 2/20 0.43
ALDH1A1 P00352 1/20 0.43
PGR P06401 1/20 0.42
CYP3A4 P08684 1/20 0.42
AR P10275 1/20 0.42
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA7 P43166 1/20 0.41
CA9 Q16790 1/20 0.41
CA14 Q9ULX7 1/20 0.41
ABCC9 O60706 4/20 0.39
ABCC8 Q09428 4/20 0.39
KCNJ11 Q14654 4/20 0.39
KCNJ8 Q15842 4/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL54917 0.85 L3MBTL1 (0.75) L3MBTL1MAPTALDH1A1CA12CA1
SCHEMBL4573229 0.82 L3MBTL1 (0.52) L3MBTL1PDK1PDK2PDK3PDK4
SCHEMBL3129785 0.81 PDK1 (0.67) L3MBTL1PDK1PDK2PDK3PDK4
SCHEMBL6655436 0.80 PDK1 (0.44) L3MBTL1PDK1PDK2PDK3PDK4
SCHEMBL18086475 0.79 L3MBTL1 (0.59) L3MBTL1PDK1PDK2PDK3PDK4
SCHEMBL202154 0.79 CA12 (0.53) L3MBTL1PDK1PDK2PDK3PDK4
SCHEMBL20124849 0.78 MAPT (0.57) L3MBTL1PDK1PDK2PDK3PDK4
SCHEMBL5523100 0.77 L3MBTL1 (0.47) L3MBTL1PDK1PDK2PDK3PDK4
SCHEMBL27893900 0.76 L3MBTL1 (0.55) L3MBTL1PDK1PDK2PDK3PDK4
SCHEMBL5199230 0.76 L3MBTL1 (0.46) L3MBTL1PDK1PDK2PDK3PDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070275968-A1 Substituted Biphenyl Derivative SANKYO COMPANY, LIMITED (JP) 2007-11-29 US claimed
EP-1798229-A1 SUBSTITUTED BIPHENYL DERIVATIVE Sankyo Company, Limited (JP) 2007-06-20 EP claimed
US-20070275968-A1 Substituted Biphenyl Derivative SANKYO COMPANY, LIMITED (JP) 2007-11-29 US disclosed
EP-1798229-A1 SUBSTITUTED BIPHENYL DERIVATIVE Sankyo Company, Limited (JP) 2007-06-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070275968-A1 Substituted Biphenyl Derivative COL2A1, COL1A1, FGFR3 L3MBTL1 2263/4885PDK1 4247/4885PDK2 3576/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.